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Clematichinenoside AR (C-AR) is a triterpene saponin isolated from the root of Clematis 
manshurica Rupr., which is a herbal medicine used in traditional Chinese medicine for 
the treatment of arthritis. C-AR exerts anti-inflammatory and immunosuppressive prop-
erties, but little is known about its action in the suppression of fibroblast activation. Low 
oxygen tension and transforming growth factor-β (TGF-β1) induction in the synovium 
contribute to fibrosis in arthritis. This study was designed to investigate the effect of 
C-AR on synovial fibrosis from the aspects of hypoxic TGF-β1 and hypoxia-inducible 
transcription factor-1α (HIF-1α) induction. In the synovium of rheumatoid arthritis (RA) 
rats, hypoxic TGF-β1 induction increased succinate accumulation due to the reversal 
of succinate dehydrogenase (SDH) activation and induced NLRP3 inflammasome 
activation in a manner dependent on HIF-1α induction. In response to NLRP3 inflam-
masome activation, the released IL-1β further increased TGF-β1 induction, suggesting 
the forward cycle between inflammation and fibrosis in myofibroblast activation. In the 
synovium of RA rats, C-AR inhibited hypoxic TGF-β1 induction and suppressed succi-
nate-associated NLRP3 inflammasome activation by inhibiting SDH activity, and thereby 
prevented myofibroblast activation by blocking the cross-talk between inflammation and 
fibrosis. Taken together, these results showed that succinate worked as a metabolic 
signaling, linking inflammation with fibrosis through NLRP3 inflammasome activation. 
These findings suggested that synovial succinate accumulation and HIF-1α induction 
might be therapeutical targets for the prevention of fibrosis in arthritis.
Keywords: TgF-β1, hiF-1α, succinate, nlrP3 inflammasome, synovial fibrosis, collagen-induced arthritis, 
clematichinenoside ar
inTrODUcTiOn
Rheumatoid arthritis (RA) is an inflammatory autoimmune disease characterized by hyperplasia of 
the synovial membranes and progressive destruction of cartilage and bone with impaired joint func-
tion. In RA, fibroblast activation and extracellular matrix (ECM) remodeling are key events respon-
sible for synovial tissue fibrosis (1, 2). Accumulating evidence has demonstrated the critical role of 
transforming growth factor-β (TGF-β) in fibrotic response. TGF-β is a secreted protein with multiple 
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functions involved in the regulation of cell differentiation, tis-
sue proliferation, and fibrogenesis. In response to inflammatory 
response, TGF-β1 drives myofibroblast activation through both 
canonical (Smad-based) and non-canonical (non-Smad-based) 
signaling pathways, leading to excessive ECM deposition and 
resultant fibrosis in synovium (3). Large amounts of TGF-β1 are 
stored in ECM accumulation; the activation and proliferation 
of myofibroblast correlate with a high expression of α-smooth 
muscle actin (α-SMA), which is considered myofibroblast marker 
(4). Similar to the action in diabetic nephropathy (5), pulmonary 
fibrosis (6), and liver fibrosis (7), TGF-β1 levels are elevated in the 
synovial fluid of arthritis patients, correlating with up-regulated 
genes involved in ECM turnover (8). Meanwhile, aberrant activa-
tion of TGF-β1 is observed in RA rats, and responsible for joint 
destruction (9). These events indicate that TGF-β1 is the control 
mediator in fibrogenesis.
Inflammation, oxidative stress, and alternation of immune 
parameters are often observed in the onset and persistence of RA 
(10, 11); however, hypoxia in the inflamed joint due to low oxygen 
tension emerges as an initial cause for these consequences in 
synovial fibrosis (12). In response to hypoxia, hypoxia-inducible 
transcription factor-1α (HIF-1α) serves as a hypoxia sensor to 
regulate cellular responses to adapt the anoxia environment. 
Meanwhile, as a transcription factor, HIF-1α induces an alterna-
tive transcriptional program, mainly enhancing gene expression 
encoding pro-inflammatory cytokines, growth factors, and ECM 
remodeling, to activate fibroblasts in special tissues, including 
adipose, liver, and kidney tissue (13–15). Inflammation induces 
fibroblast activation and fibrosis, while activation fibroblasts 
secrete pro-inflammatory cytokines and tissue-degrading 
enzymes to enhance inflammation and exacerbate tissue injury, 
forming a circle of regulation between inflammation and fibro-
blast activation. Although hypoxia and HIF-1α induction are 
observed in the synovium of arthritis (12, 16), the special role 
of HIF-1α with molecular signaling in fibrosis is still unknown.
Succinate, as an intermediate in citric acid cycle (CAC), is a 
universal metabolic signature response to hypoxia conditions 
(17). More recently, Tannahill et al. show that succinate induces 
IL-1β secretion through HIF-1α induction in macrophages (18). 
This finding elucidates that succinate might act as a metabolic 
signature to trigger inflammation under hypoxic conditions. As 
IL-1β maturation is mediated through NLRP3 inflammasome 
(19), hypoxic IL-1β production should be a result from NLRP3 
inflammasome activation. In view of the important role of NLRP3 
inflammasome in RA (20), we hypothesized that IL-1β might act 
as an inflammatory signaling for TGF-β1 activation in synovial 
fibrosis.
Clematichinenoside AR (C-AR) is a triterpene saponin 
isolated from the root of Clematis manshurica Rupr. As a herbal 
medicine, the root of C. manshurica Rupr. (Wei Ling Xian) has 
been used for the treatment of arthritis in traditional Chinese 
medicine with a prevalent clinical practice in many formulae 
defined in the Chinese Pharmacopoeia (2015 edition) and C-AR 
is considered the effective component for the treatment of RA 
(21). Previous study showed that C-AR exerts anti-inflammatory 
and immunosuppressive properties and ameliorate collagen-
induced arthritis (CIA) in rats (22, 23). But up to now, little is 
known about its molecular targets and working pathways in 
the prevention of fibrosis. For these, we investigated the effects 
of C-AR on synovial fibrosis in CIA in rats with focus on the 
regulation of NLRP3 inflammasome activation and TGF-β1 
induction from the aspects of succinate accumulation and HIF-
1α induction. Our work demonstrated that succinate increased in 
synovial tissue due to low oxygen tension and acted as a metabolic 
signaling to induce TGF-β1 induction through NLRP3 inflam-
masome activation with the involvement of HIF-1α. C-AR inhib-
ited succinate-mediated NLRP3 inflammasome activation by 
attenuating synovial hypoxia and HIF-1α induction, and thereby 
prevented fibroblast activation in CIA. These results suggested 
that synovial succinate accumulation and HIF-1α induction 
might be therapeutical targets for the prevention of fibrosis in RA.
MaTerials anD MeThODs
Materials
Clematichinenoside AR was isolated from the roots of 
C. manshurica Rupr. as described previously (24), and the purity 
(>98%) was determined by high performance liquid chromatog-
raphy (HPLC) analysis. The structure of C-AR was showed in 
Figure S1 in Data Sheet in Supplementary Material.
Complete Freund’s adjuvant (CFA) (#7001), incomplete 
Freund’s adjuvant (IFA) (#7002), and bovine type II collagen 
(#20021) were obtained from Chondrex, Inc. (Redmond, WA, 
USA). Recombinant Human TGF-β1 (PeproTech Inc., USA) and 
murine IL-1β (PeproTech Inc., USA) were dissolved in citric acid 
as a stock solution and then further diluted with PBS contain-
ing 5% trehalose before use. Digoxin and PX-478 were obtained 
from NRCCRM (Beijing, China) and Taizhou Rico Biological 
Technology Co., Ltd. (Taizhou, China), respectively. These agents 
were dissolved in dimethyl sulfoxide (DMSO) as a stock solution 
and the final working concentration of DMSO was <0.1% (v/v). 
Dimethyl malonate (V900555), dimethyl succinate (V900547), 
and aminooxyacetate (AOA, C13408) were provided by Sigma 
(St. Louis, MO, USA). The following items were purchased from 
the cited commercial sources: anti-IL-1β antibody (MAB201) 
(R&D, USA); anti-NLRP3 (NBP2-12446) and Novus Biologicals 
(Littleton, CO, USA); anti-α-SMA (ab32575), anti-cleaved cas-
pase-1 (ab1872), anti-HIF-1α (ab51608), anti-TGF-β1 (ab64715), 
Goat Anti-Rabbit IgG H&L (Alexa Fluor 488) (ab181448), 
and Abcam (Cambridge, MA, USA); anti-GAPDH (AP0063), 
Goat Anti-Rabbit IgG (H+L) HRP (BS13278), and Bioworld 
Technology (St. Paul, MN, USA).
induction and assessment of cia  
and Drug administration
Female Wistar rats (130–140  g, n =  50) were supplied by the 
Laboratory Animal Center of Yangzhou University (Yangzhou, 
China). Rats were housed under standard laboratory condition 
of constant temperature (23 ± 1°C) and 55 ± 5% relative humid-
ity with a 12-h alternate light/dark cycle, fed with standard diet 
and tap water. Animal welfare and all experimental protocols 
were approved by the Animal Ethics Committee of China 
Pharmaceutical University.
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To prepare CIA in the rat, on day 0, bovine type II colla-
gen was emulsified in CFA (1:1, v/v) and then administrated 
intradermally into the base of rat tail, as the primary immuniza-
tion. On day 7, rats were given a booster injection of bovine 
type II collagen emulsified in IFA (1:1, v/v), as the secondary 
immunization. After that, rats were administrated with C-AR 
(50 mg/kg, by gavage) or digoxin (100 μg/kg, by intraperitoneal 
injection) once a day for 2 weeks. The choice of dosage value for 
C-AR was based on the published reports (22, 23). Normal and 
model rats were orally given an equal volume of distilled water 
in parallel.
The clinical symptoms were recorded every 3 days since the 
secondary immunization, with arthritis index scores according to 
the following criteria: score 0, no swelling or inflammation; score 
1, slight swelling and/or redness of paw; score 2, swelling in two 
or more joints; score 3, pronounced swelling with more than two 
joints; and score 4, severe swelling with joint rigidity. Meanwhile, 
paw swelling and body weight were recorded during the course, 
of which paw swelling was expressed as the volume of increase 
with respect to day 0 volume.
Preparation of rat synovial Fibroblast  
and cell culture
Rat synovial fibroblasts were obtained as previously described 
(25). In brief, the isolated synovium was minced and digested 
with 4 mg/ml collagenase II (Sigma, USA) for 2 h at 37°C and 
then cultured in RPMI Medium 1640 until the cells outgrowing 
from the explants. Passages 3–6 of the synovial fibroblasts were 
used for the experiments.
To specifically suppress HIF-1α expression, NIH-3T3 
cells (a  cell line of embryo fibroblasts) were grown to 60% 
confluence and then transfected with small interfering RNA 
(siRNA) duplexes specific for HIF-1α (sc-35562, Santa Cruz 
Biotechnology) or control siRNA (sc-37007) by siRNA transfec-
tion reagent (sc-29528). After transfection, cells were cultured in 
Dulbecco’s Minimum Essential Medium (DMEM) for 24–48 h 
before experiments.
Quantitative real-time Pcr analysis
Total RNA from rat synovium was extracted with TRIzol Reagent 
(Beyotime Biotechnology Corporation, China), and cDNA was 
synthesized by an All-In-One-RT MasterMix synthesis kit (ABM, 
Canada), following the manufacturer’s instructions. cDNA was 
amplified by quantitative real-time PCR with the SYBR Green 
I PCR kit (BIO-RAD, USA) and the CFX96™ Realtime System 
(BIO-RAD, USA). Primer sequences are listed in Table S1 in Data 
Sheet in Supplementary Material. The mRNA level of individual 
genes was normalized to β-actin and calculated by 2−ΔΔCt data 
analysis method (26).
Biochemical assay
Synovial tissue of RA was lysed in ice-cold RIPA buffer with 
Tissue Lyser, and then centrifuged at 13,000  g for 15  min at 
4°C. The supernatant was collected. The contents of lactate and 
succinate and the activity of succinate dehydrogenase (SDH) in 
the supernatant were assayed with the commercial Kits, while 
IL-1β was measured with ELISA Kit (Neobioscience Technology 
Co., China). For the assay in cultured cells, confluent synovial 
fibroblasts or transfected NIH-3T3 cells were pretreated with 
indicated agents and then stimulated with TGF-β1 (10 ng/ml) or 
dimethyl succinate (5 mM) for 48 or 8 h. After incubation, lactate 
and IL-1β in the supernatant and succinate and SDH activity in 
the lysed cells were assayed as mentioned above.
Western Blot analysis
For protein analysis, synovial fibroblasts or transfected NIH-3T3 
cells were lysed in ice-cold RIPA buffer and incubated in an ice 
bath for 45 min. Protein was obtained by centrifugation at 12,000 g 
for 20 min at 4°C and quantified with Bicinchoninic Acid Protein 
Assay Kit (Beyotime Biotechnology Corporation, China). Equal 
amount of protein was separated on polyacrylamide SDS gels and 
transferred to polyvinylidene difluoride (PVDF) membranes by 
electrophoresis, following incubation with the specific primary 
antibodies and HRP-conjugated secondary antibody. The values 
of band intensities were detected by enhanced chemilumines-
cence (ECL) and densitometry was analyzed quantitatively by 
Image-Pro Plus 6.0 (IPP 6.0) software.
histopathological and 
immunohistochemical examination
Synovial tissue were fixed with 4% (w/v) paraformaldehyde, 
embedded in paraffin, and then sectioned at 5-μm thickness. The 
sections were dewaxed using xylene and dehydrated in a gradient 
of alcohol. For the histological evaluation, the tissue slices were 
stained with hematoxylin and eosin (H&E) or Masson’s trichrome 
staining, according to standard protocols. For immunohisto-
chemistry analysis, the sections were subjected to 3% hydrogen 
peroxide to quench the endogenous peroxidase activity, and then 
incubated with specific primary antibodies and HRP-conjugated 
secondary antibodies. Images were observed and captured with 
an optical microscope (Olympus, Japan).
Pimonidazole staining and 
immunofluorescence
To investigate synovial hypoxia, rats were injected with 
hypoxyprobe (pimonidazole HCL) (Hypoxyprobe™-1 Plus 
Kit, Burlington, VT, USA) at a dosage of 60 mg/kg for 45 min 
prior to sacrifice. Immunoperoxidase staining for hypoxyprobe 
binding in a formalin-fixed paraffin embedded synovium sec-
tion using 1:100 dilution of FITC-MAb1 and 1:100 dilution 
of horseradish peroxidase conjugated rabbit anti-FITC IgG. 
The image was observed by inverted fluorescence microscope 
(Nikon ECLIPSE Ti-s).
For cellular hypoxia, synovial fibroblasts were detected after 
adding hypoxyprobe (20 μM) and treated with C-AR or PX-478, 
then, exposed to hypoxia (1% O2, 4  h) or TGF-β (10  ng/ml, 
48 h). For immunofluorescence assay, synovial fibroblasts were 
cultured on coverslips, pretreated with C-AR, and then stimu-
lated with TGF-β1 (10 ng/ml, 48 h) or dimethyl succinate (5 mM, 
8 h). After incubation, synovial fibroblasts were fixed with 4% 
FigUre 1 | c-ar attenuated synovial TgF-β1 expression and fibrosis in collagen-induced arthritis (cia) rats. (a,B) The severity of arthritis evaluated by 
the paw swelling (a) and the arthritis index scores (B) in rats. *p < 0.05 vs. the model; #p < 0.05 vs. the normal (n = 8); (c) histopathological examination in the 
synovial tissue of CIA rats (original magnification, 100×; scale bar, 50 μm); (D–F) immunohistochemical staining of TGF-β1 and α-SMA and Masson’s trichrome 
staining in the synovial tissue of CIA rats (original magnification, 100×; scale bar, 50 μm); (g) the mRNA levels of Col1α, Col3α, and LOX in the synovial tissue of CIA 
rats (the data were expressed as the fold change relative to the normal). The results were expressed as the mean ± SD of four independent experiments. *p < 0.05 
vs. the model; #p < 0.05 vs. the indicated treatment.
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paraformaldehyde in PBS for 15  min, and then blocked with 
5% BSA containing 0.1% Triton X-100 for 60  min. Following 
incubation with primary antibodies and secondary antibodies, 
cells were visualized under a confocal scanning microscope 
(Zeiss LSM 700).
statistical analysis
All of the experimental results are expressed as the mean ± SD 
(standard deviation), and each experiment was performed a 
minimum of four times. Data were analyzed by two-tailed t-test, 
or one-way ANOVA test with Student–Newman–Keuls test for 
comparison of two groups. A value of p < 0.05 was considered to 
be statistically significant.
resUlTs
c-ar alleviated TgF-β1 expression and 
synovial Fibrosis in cia rats
Collagen challenge induced arthritis in rats, as evidenced by red 
swelling in the paw and functional impairment (Figures 1A,B). 
Administration of C-AR (50  mg/kg) and HIF-1α inhibitor 
digoxin (100 μg/kg) reduced swollen ratio and ameliorated the 
clinical symptoms indicated the reduced arthritis index scores 
(Figures 1A,B). Histological examination showed that C-AR and 
digoxin treatment ameliorated synovial hyperplasia and conges-
tion with a reduction in the infiltration of inflammatory cells in 
the synovial tissue (Figure  1C). In addition, C-AR treatment 
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improved body weight gain in the course of arthritis (Figure 
S2 in Data Sheet in Supplementary Material). These results well 
demonstrated the beneficial effects of C-AR on the amelioration 
of arthritis in rats.
Meanwhile, we examined fibrosis in the synovial tissues. 
Immunohistochemistry staining showed TGF-β1 and α-SMA 
overexpression in the synovial tissue, indicating fibroblast activa-
tion, whereas these alternations were prevented by C-AR and 
digoxin treatment (Figures 1D,E). Masson trichrome stain sec-
tions showed an attenuated fibrosis in C-AR or digoxin-treated 
CIA rats (Figure 1F). Coincidentally, C-AR treatment normal-
ized gene expressions for Col1α, Col3α, and LOX in synovial 
tissue (Figure  1G). These results showed that C-AR prevented 
fibrosis in synovial tissue. Digoxin, a HIF-1α inhibitor, effectively 
reduced protein or gene expressions of TGF-β1, α-SMA, and 
ECM, indicative of the potential involvement of HIF-1α.
c-ar attenuated hypoxia and inhibited 
hiF-1α induction in the synovial Tissue  
of cia rats
Accompanied with fibrosis, hypoxia also occurred in synovial 
tissue, indicated by increased staining of hypoxia adducts with 
pimonidazole (Figure 2A). C-AR and digoxin treatment attenu-
ated hypoxia and then inhibited HIF-1α protein accumulation 
in the synovium of CIA rats (Figures 2A,B). Meanwhile, HIF-
1α gene expression was also reduced in the synovium (Figure 
S3 in Data Sheet in Supplementary Material). Similarly, C-AR 
treatment effectively attenuated hypoxia and reduced HIF-1α 
accumulation at concentrations ranging from 0.1 to 10 μM in 
synovial fibroblasts exposed to 1% O2 (Figures 2C,D). HIF-1α 
inhibitor PX-478 showed a similar regulatory tendency as C-AR. 
TGF-β1 stimulation increased HIF-1α induction with increased 
pimonidazole staining in synovial fibroblasts, indicating that 
TGF-β1-induced HIF-1α induction in a manner of low oxygen 
tension-dependent (Figures 2E,F). C-AR as well as PX-478 pre-
vented TGF-β1-induced low oxygen tension in fibroblasts, and 
thereby inhibited HIF-1α induction with reduced lactate accu-
mulation (Figure S3 in Data Sheet in Supplementary Material). 
Meanwhile, C-AR treatment reduced lactate accumulation in 
the synovial tissue and fibroblasts (Figure S4 in Data Sheet in 
Supplementary Material). These results in vivo and in vitro dem-
onstrated that C-AR reduced HIF-1α accumulation by preventing 
low oxygen tension.
c-ar reduced succinate accumulation  
in synovial Tissue
Accompanied with local hypoxia, succinate accumulated in the 
synovium of CIA rats (Figure  3A). C-AR and digoxin treat-
ment reduced succinate accumulation with inhibition of SDH 
activity (Figures 3A,B). Consistent with the regulation in vivo, 
C-AR treatment inhibited SDH activity and reduced succinate 
accumulation in a concentration-dependent manner in synovial 
fibroblasts when exposed to TGF-β1 treatment (Figures 3C,D). 
In CAC, SDH converts succinate to fumarate, inhibition of SDH 
should increase succinate accumulation. However, we found that 
SDH inhibitor dimethyl malonate inhibited TGF-β1-induced 
succinate production in fibroblasts. In view of the increased SDH 
activity, this result suggested that SDH might act in reverse for 
succinate formation. As an inhibitor of malate/aspartate shuttle 
(MAS), AOA reduced succinate accumulation with inhibited 
SDH activity, suggesting that MAS pathway might provide sub-
strate for the reversal succinate production (Figure 3E).
c-ar inhibited nlrP3 inflammasome 
activation in synovial Tissue
We observed increased IL-1β production accompanied with 
NLRP3 and cleaved caspase-1 overexpression in synovial tissue 
(Figures  4A–C). C-AR and digoxin administration attenuated 
NLRP3 and cleaved caspase-1 expression, and then reduced IL-1β 
production (Figures 4A–C), which was indicative of the role in 
suppressing NLRP3 inflammasome activation. As succinate is 
documented to promote IL-1β in macrophages, we investigated 
the possible implication of succinate in synovial IL-1β produc-
tion. As shown in Figure 4D, SDH inhibitor dimethyl malonate 
inhibited TGF-β1-induced IL-1β production, indicating the 
involvement of succinate. Dimethyl succinate is a cell permeable 
derivative of succinate readily taken up by cells, where it is then 
amplified thereby increasing succinate level. Similar to TGF-β1, 
succinate also increased IL-1β production, despite less extent than 
TGF-β1 (Figure 4D). In line with the action, we observed suc-
cinate enhanced NLRP3 induction in a concentration-dependent 
way (Figure 4E). These results suggested that TGF-β1-induced 
NLRP3 inflammasome activation through succinate, at least in 
part. HIF-1α inhibitor PX-478 diminished the enhanced effect of 
succinate on IL-1β production and NLRP3 expression, suggesting 
the potential involvement of HIF-1α in NLRP3 inflammasome 
activation (Figures 4D,E).
succinate induced nlrP3 inflammasome 
activation via hiF-1α
In synovial fibroblasts, succinate increased HIF-1α production 
(Figure  5A). HIF-1α was distributed in the cytosol, and in 
response to succinate stimulation, HIF-1α accumulation was 
accompanied by its translocation to the nucleus (Figure  5B). 
To directly address the functional interaction between HIF-1α 
and NLRP3 inflammasome activation, we investigated NLRP3 
expression and IL-1β secretion in NIH-3T3 cells, a cell line of an 
embryo fibroblast, by transfecting them with siRNA of HIF-1α. 
Knockdown of HIF-1α diminished the enhancing effects of suc-
cinate on NLRP3 expression and IL-1β secretion (Figures 5C,D), 
indicating that HIF-1α induction was required for succinate-
associated NLRP3 inflammasome activation.
c-ar attenuated synovial Fibroblast 
activation with regulation il-1β secretion
To know the contribution of succinate and NLRP3 inflamma-
some activation to synovial fibroblasts activation, we observed 
TGF-β1 and α-SMA protein expression in fibroblasts exposed 
to dimethyl succinate. Succinate challenge increased TGF-β1 
and α-SMA expression, whereas these increased expressions 
were reduced by neutralizing IL-1β with anti-IL-1β antibody 
FigUre 2 | c-ar alleviated hypoxia and suppressed hiF-1α expression in the synovial tissue of collagen-induced arthritis (cia) rats. (a) Pimonidazole 
staining in the synovial tissue of CIA rats (original magnification, 200×; scale bar, 50 μm); (B) immunohistochemical staining of HIF-1α in the synovial tissue of CIA 
rats (original magnification, 100×; scale bar, 50 μm); (c) synovial fibroblasts were cultured under hypoxic conditions (1% O2) for 24 h and pimonidazole staining was 
viewed under a confocal scanning microscope (original magnification, 630×; scale bar, 50 μm); (D) HIF-1α expression in synovial fibroblasts cultured under hypoxic 
conditions (1% O2) for 24 h; (e,F) pimonidazole staining (e) and HIF-1α expression (F) in synovial fibroblasts exposed to TGF-β1 (original magnification, 630×; scale 
bar, 20 μm). Data were expressed as the mean ± SD from four independent experiments. *p < 0.05 vs. the model; #p < 0.05 vs. the indicated treatment.
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treatment (Figures 6A,B), suggesting the potential role of IL-1β 
in succinate-mediated fibroblasts activation. For further confir-
mation, we observed the expression of TGF-β1 and α-SMA in 
fibroblasts to IL-1β stimulation. As shown in Figures 6C,D, incu-
bation of fibroblasts with IL-1β resulted in TGF-β1 and α-SMA 
proteins accumulation, and these alternations were reversed 
by pretreatment with C-AR. Together with above-mentioned 
results, they indicated that succinate worked as a metabolic sign-
aling, amplifying TGF-β1 action in fibroblasts through NLRP3 
inflammasome activation. C-AR reduced succinate accumulation 
and thereby blocked the forward cycle toward sustained fibroblast 
activation (Figure 6E).
FigUre 3 | c-ar reduced succinate accumulation in synovial tissue. (a,B) Succinate abundance (a) and succinate dehydrogenase (SDH) activity (B) in 
synovial tissue of collagen-induced arthritis (CIA) rats; (c,D) SDH activity (c) and the level of succinate (D) in synovial fibroblasts stimulated with TGF-β1; (e) 
proposed pathway for reversal succinate accumulation. The results all above were expressed as the mean ± SD (n = 4). *p < 0.05 vs. the model; #p < 0.05 vs. the 
indicated treatment.
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DiscUssiOn
Inflammation and fibrosis persistently exist in the pathological 
progress of RA. In the present study, we demonstrated that IL-1β-
mediated inflammation led to fibroblast activation through TGF-
β1 induction, which further stimulated IL-1β production for the 
persistent fibroblast activation. Succinate accumulation acted as 
a metabolic signaling linking IL-1β and TGF-β1 induction in the 
ahead cycle, establishing the cross-talk between inflammation 
and fibrosis and further exacerbating tissue injury in RA.
Rheumatoid arthritis is characterized by synovial proliferation 
and invasiveness, in which fibroblast activation links inflamma-
tion to ECM remodeling, contributing to fibrosis and joint injury. 
C-AR reduced joint swelling with functional improvement in 
arthritis rats, and the therapeutic effects should be related to the 
suppression of synovial invasiveness, as we observed that C-AR 
ameliorated synovial hyperplasia and congestion in RA rats. TGF-
β1 is considered to be the master regulator of fibrosis, because it 
activates myofibroblasts, promotes expression of ECM genes, and 
inhibits ECM degradation (3). As a cellular contractile apparatus, 
α-SMA induction is a marker of myofibroblast formation. C-AR 
suppressed TGF-β1 and α-SMA induction, and thus prevented 
ECM deposits in the synovium. C-AR is documented to exert 
anti-inflammatory activity in RA rats (22, 23); the present work 
further showed that C-AR reduced ECM deposits via suppression 
of myofibroblast activation, elucidating the special role of C-AR 
in anti-fibrosis.
Hypoxia-inducible transcription factor-1α inhibitor digoxin 
inhibited myofibroblast activation in the synovium, indicating 
the potential role of HIF-1α in RA. Consistently, we observed 
low oxygen tension in the synovium. The dysregulated archi-
tecture of the microvasculature in synovial invasiveness and the 
increased demand of oxygen during the inflammatory response 
should be the cause of synovial hypoxia (27). C-AR as well as 
digoxin inhibited inflammation and prevented fibrosis, and these 
actions should attenuate hypoxia by reducing oxygen demand in 
FigUre 4 | c-ar inhibited nlrP3 inflammasome activation in synovial tissue. (a,B) Immunohistochemistry staining of NLRP3 expression (a) and cleaved 
caspase-1 activation (B) in the synovial tissue of collagen-induced arthritis (CIA) rats (original magnification, 100 × ; scale bar, 50 μm). (c,D) IL-1β in the synovial 
tissue of CIA rats (c) and TGF-β1-stimulated synovial fibroblasts (D) were measured by ELISA Kits (n = 6); (e) NLRP3 protein expression in succinate-stimulated 
synovial fibroblasts. The results were derived from four independent experiments for immunohistochemistry staining and Western blot and expressed as the 
mean ± SD. *p < 0.05 vs. the model; #p < 0.05 vs. the indicated treatment.
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the synovium. Interestingly, we found that accompanied with 
low oxygen tension, succinate accumulated in the synovium. 
Succinate is an intermediate of the mitochondrial CAC and 
recent studies demonstrated the special role of succinate in 
inflammation (18, 28). In CAC, SDH catalyzes succinate to 
produce fumarate, and theoretically, inhibition of SDH should 
lead to succinate accumulation. Indeed, SDH inhibition induces 
succinate accumulation in tumor cells (29). However, in the pre-
sent study, we observed succinate accumulation accompanied 
with increased SDH activity. SDH inhibitor dimethyl malonate 
reduced succinate accumulation, indicating that succinate 
accumulation should be a result of the reversal of SDH activity. 
In ischemic heart, succinate accumulation is proposed to be a 
result of the reversed SDH activation due to the supply of fuma-
rate from the MAS (30). Consistent with the hypothesis, MAS 
inhibitor AOA suppressed SDH activity and reduced succinate 
accumulation in TGF-β1-stimulated synovial myofibroblasts. 
C-AR inhibited SDH activity and thereby prevented succinate 
accumulation. In macrophages, LPS-induced succinate accumu-
lation is proposed to be a consequence of glycolytic reprogram-
ing (18, 28); our work showed that in myofibroblasts, TGF-β1 
increased succinate accumulation through the reversal of SDH, 
which might be the alternative way for inflammatory succinate 
production.
In RA rats, we observed TGF-β1 induction in the synovium 
and showed that TGF-β1 promoted succinate accumulation 
in myofibroblast. In macrophages, succinate promotes IL-1β 
production in a manner dependent on HIF-1α (18). As IL-1β 
is a crucial mediator of the inflammatory response and plays an 
important role in arthritis (31), it is tempted to know if succinate 
contributed to IL-1β production in activated fibroblasts. In the 
synovium of RA rats, NLRP3 induction and increased IL-1β pro-
duction suggested the potential implication of succinate. NLRP3 
inflammasome complex is assembled by NLRP3, the adaptor 
protein ASC and caspase-1, and the action is to promote IL-1β 
maturation and secretion through cleavage by caspase-1 (20). 
In myofibroblasts, succinate induced NLRP3 expression with an 
increase of IL-1β production, indicating inflammasome activa-
tion. In tumor cells, succinate is demonstrated to stabilize HIF-1α 
protein by inhibiting proteasomal degradation (30). Consistently, 
in the present study succinate increased HIF-1α accumulation 
and knockdown of HIF-1α diminished its enhancing effects on 
NLRP3 induction and IL-1β production, indicating that succi-
nate induced IL-1β production through NLRP3 inflammasome 
activation in a manner dependent of HIF-1α. Recently, Vande 
Walle et al. demonstrated NLRP3 inflammasome activation in RA 
(22), and our work further elucidated the special role of succinate 
and HIF-1α in NLRP3 inflammasome activation. C-AR reduced 
succinate accumulation and inhibited HIF-1α induction, thereby 
preventing NLRP3 inflammasome activation in the synovium of 
RA rats. Previous works demonstrated the anti-inflammatory 
effects of C-AR on RA rats (22, 23), and our work indicated that 
suppression of inflammasome activation should be the unifying 
mechanism for the same action.
Inflammatory response and fibrosis occur simultaneously 
in the invasive synovial tissue of RA and it is generally consid-
ered that TGF-β1 is a crucial mediator linking inflammation 
to fibroblast activation (3, 9). In response to inflammation, 
FigUre 5 | succinate induced nlrP3 inflammasome activation via hiF-1α. (a) HIF-1α expression in succinate-stimulated synovial fibroblasts. *p < 0.05 vs. 
the normal control group. (B) HIF-1α translocation in succinate-stimulated synovial fibroblasts was viewed under a confocal scanning microscope (original 
magnification, 630×; scale bar, 10 μm); (c,D) NLRP3 expression (c) and IL-1β (D) production in transfected NIH-3T3 cells (HIF-1α siRNA). The results above were 
derived from four independent experiments and expressed as the mean ± SD for ELISA (n = 6). *p < 0.05 vs. the HIF-1α siRNA; #p < 0.05 vs. the indicated 
treatment.
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TGF-β1 induces myofibroblast activation, leading to fibrosis. RA 
is a progressive inflammatory disease, and here we showed that 
succinate/HIF-1α signaling should be the important cause for 
persistent TGF-β1 activation. In addition to reprogram adaptive 
response for anoxia metabolism, HIF-1α exerts the ability to 
induce fibrosis in special tissues (13–15). Here, we demonstrated 
the involvement of NLRP3 inflammasome activation, because 
HIF-1α was essential for succinate-mediated NLRP3 inflamma-
some activation, which further promoted TGF-β1 and α-SMA 
induction through IL-1β action. In myofibroblasts, TGF-β1 
increased hypoxic succinate accumulation and subsequent 
NLRP3 inflammasome activation, indicating that TGF-β1 was an 
initial cause for IL-1β production, responsible for inflammatory 
response. As an important inflammatory mediator, IL-1β in turn 
further enhanced TGF-β1 activation, demonstrating the positive 
feedback regulation of fibroblast activation. In view of the special 
role of TGF-β1 and IL-1β in RA, the reciprocal regulate estab-
lished a cycle or cross-talk between inflammation and fibrosis. 
In the forward cycle, succinate worked as a metabolic signaling 
responsible for sustained TGF-β1 induction, contributing to 
fibrosis in the synovial tissue of RA. C-AR blocked the cross-talk 
between IL-1β and TGF-β1 by reducing succinate accumulation, 
and thereby inhibited inflammation and prevented fibrosis in 
synovial tissue of RA.
Taken together, our work showed that anoxic succinate accu-
mulation induced NLRP3 inflammasome activation through 
HIF-1α induction, then exacerbated inflammation and fibrosis in 
the synovium of RA rats. C-AR reduced succinate accumulation 
by attenuating synovial hypoxia and then inhibited inflammation 
and fibrosis by preventing NLRP3 inflammasome activation. 
Consistent with the published studies which show that succinate 
accumulated in the synovial fluids from RA patients (32, 33), the 
finding of the role of succinate/NLRP3 inflammation signaling 
not only provides insight into the connection between inflamma-
tion and fibroblast activation but also reveals therapeutic targets 
for RA treatment. Moreover, our work presented a potential 
therapeutic strategy for the application of C-AR in the manage-
ment of RA.
FigUre 6 | TgF-β1 and α-sMa induction in synovial fibroblasts. (a,B) TGF-β1 and α-SMA expression in succinate-stimulated synovial fibroblasts; (c,D) 
TGF-β1 and α-SMA in IL-1β-stimulated synovial fibroblasts. The results all above are expressed as the mean ± SD of four independent experiments. *p < 0.05 vs. 
the model group; #p < 0.05 vs. the indicated treatment. (e) The proposed pathway for C-AR action in the suppression of synovial fibrosis.
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